ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NMDP Named ‘Best Place to Work’ Fourth Year in a Row

Global cell therapy nonprofit honored in top 3 of the 'extra large' companies, recognizing its exceptional employees, workplace culture and life-saving mission

MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, announced the Minneapolis / St. Paul Business Journal honored the organization for the fourth consecutive year as a top workplace, notching third place in the 'extra large' company category of 2024 Best Places to Work, which recognizes Twin Cities-based organizations that excel at creating positive, thriving environments for their employees.

With more than 1,000 Minnesota-based employees and another 600-strong around the world, NMDP has grown exponentially since its inception in 1987 into a ground-breaking blood stem cell research, product and service provider as well as registry, helping patients facing life-threatening blood cancers and diseases. The Twin Cities-founded nonprofit has impacted more than 130,000 lives through cell therapy – giving a second chance to patients at home and abroad.

“The dedication of our people is unparalleled, and in my decade here, I’m continually inspired by our team's determination to embody our mission,” said Amy Ronneberg, CEO of NMDP. "We all play different roles and are united in a common vision to save more patient lives. It's our collective commitment to donors, patients, volunteers, supporters and partners that enables us to advance breakthrough research, deliver superior service and expand equitable access to transplant for patients in need.”

Living Out Our Mission
For many NMDP employees, the organization’s mission is personal. More than 30 current employees have donated potentially life-saving blood stem cells; some have received these donations themselves, often inspiring them to choose careers at NMDP. About 165 serve as volunteer couriers, spending their free time carefully transporting donated cells to transplant centers across the U.S. and world to ensure patients can have a second chance at life.

NMDP employee Cortney Alleyne serves as a patient navigator, helping to guide patients and their families every step of the way through the transplant journey, from diagnosis through recovery. She is also a blood stem cell donor, helping to cure her sister from sickle cell disease, a blood disorder that transplant treats.

Bioinformatics scientist Ray Sajulga also serves as an NMDP volunteer courier and has delivered blood stem cells to patients on trips totaling over 17,000 miles to date. An expert in software development, Ray translates research insights into bedside tools, enabling transplant centers to continually improve how they help save patients' lives. These tools optimize partially matched transplants and identify gaps that affect how patients in underserved populations access this life-saving treatment.

"Our employees are the lifeblood of our organization and their passion and dedication create a powerful alchemy that fuels our ambition – to build a world where every patient can receive their life-saving blood stem cell therapy,” said Ronneberg. “Being a four-time honoree is a testament to the unique culture we’ve created together and will propel us toward our five-year goals of impacting 10,000 patient lives and doubling the number of ethnically diverse patients accessing transplant."

About the 2024 Minneapolis / St. Paul Business Journal 'Best Places to Work' Awards
Together with Omaha, Neb.-based Quantum Workplace, the Minneapolis / St. Paul Business Journal identified 70 companies in the region that scored high marks from their employees when asked to rate their employers on a variety of questions related to leadership, communication and more. The honorees are ranked by their employee survey score in the Aug. 23 Best Places to Work special publication of the Journal, featuring all 70 winners. 

About NMDPSM 
At NMDPSM, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives. Learn more at nmdp.org.

Contact: 
Jess Ayers
media@nmdp.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/df5be322-b191-4c62-98f2-2a3ae407acba


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.